We serve Chemical Name:4-(2-Chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one CAS:436088-67-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(2-Chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one
CAS.NO:436088-67-4
Synonyms:4-(2-chloroacetyl)-1,3-dihydroquinoxalin-2-one
Molecular Formula:C10H9ClN2O2
Molecular Weight:224.64400
HS Code:2933990090
Physical and Chemical Properties:
Melting point:0ºC
Boiling point:0ºC
Density:1.382g/cm3
Index of Refraction:1.591
PSA:49.41000
Exact Mass:224.03500
LogP:1.41350
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-(2-chloroacetyl)-1,3-dihydroquinoxalin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(2-chloroacetyl)-1,3-dihydroquinoxalin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(2-chloroacetyl)-1,3-dihydroquinoxalin-2-one Use and application,4-(2-chloroacetyl)-1,3-dihydroquinoxalin-2-one technical grade,usp/ep/jp grade.
Related News: You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs. 4-(2-Chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one manufacturer You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs. 4-(2-Chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one supplier FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. 4-(2-Chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one vendor High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies. 4-(2-Chloro-acetyl)-3,4-dihydro-1H-quinoxalin-2-one factory The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.
